{"id":"https://openalex.org/W1971925804","doi":"https://doi.org/10.1111/j.1399-0039.1983.tb00169.x","title":"HLA antigen frequency in erythema multiforme and in recurrent herpes simplex","display_name":"HLA antigen frequency in erythema multiforme and in recurrent herpes simplex","publication_year":1983,"publication_date":"1983-03-01","ids":{"openalex":"https://openalex.org/W1971925804","doi":"https://doi.org/10.1111/j.1399-0039.1983.tb00169.x","mag":"1971925804","pmid":"https://pubmed.ncbi.nlm.nih.gov/6574617"},"language":"en","primary_location":{"id":"doi:10.1111/j.1399-0039.1983.tb00169.x","doi":"https://doi.org/10.1111/j.1399-0039.1983.tb00169.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1399-0039.1983.tb00169.x","pdf_url":null,"source":{"id":"https://openalex.org/S141055564","display_name":"Tissue Antigens","issn_l":"0001-2815","issn":["0001-2815","1399-0039"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tissue Antigens","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072462908","display_name":"Derek Middleton","orcid":"https://orcid.org/0000-0002-6688-8642","observed_orcids":["https://orcid.org/0000-0002-6688-8642"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"D. Middleton","raw_affiliation_strings":["Northern Ireland Tissue Typing Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Ireland Tissue Typing Laboratory","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111655993","display_name":"Tetiana Hutchison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802808109","display_name":"Belfast City Hospital","ror":"https://ror.org/02405mj67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289110261","https://openalex.org/I2802808109"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T. H. Hutchison","raw_affiliation_strings":["Dermatology Unit, Belfast City Hospital, Northern Irel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Unit, Belfast City Hospital, Northern Irel","institution_ids":["https://openalex.org/I2802808109"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041813379","display_name":"J. Lynd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Lynd","raw_affiliation_strings":["Northern Ireland Tissue Typing Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Ireland Tissue Typing Laboratory","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072462908"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7753,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.67643181,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"21","issue":"3","first_page":"264","last_page":"267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.015799999237060547,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hla-antigens","display_name":"HLA antigens","score":0.8659999966621399},{"id":"https://openalex.org/keywords/erythema-multiforme","display_name":"erythema multiforme","score":0.9829999804496765},{"id":"https://openalex.org/keywords/recurrent-herpes-simplex","display_name":"recurrent herpes simplex","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hla-b15","display_name":"HLA-B15","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hla-frequencies","display_name":"HLA frequencies","score":0.5220000147819519},{"id":"https://openalex.org/keywords/genetic-susceptibility","display_name":"genetic susceptibility","score":0.5559999942779541},{"id":"https://openalex.org/keywords/disease-association","display_name":"disease association","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C2781320243","wikidata":"https://www.wikidata.org/wiki/Q1363732","display_name":"Erythema multiforme","level":2,"score":0.8704220652580261},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6888790130615234},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6279079914093018},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6091316342353821},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5508376359939575},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49350154399871826},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.45406976342201233},{"id":"https://openalex.org/C2910492473","wikidata":"https://www.wikidata.org/wiki/Q18026920","display_name":"HLA-B Antigens","level":4,"score":0.4347928762435913},{"id":"https://openalex.org/C2780678043","wikidata":"https://www.wikidata.org/wiki/Q743241","display_name":"Group A","level":2,"score":0.4325265884399414},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.32335883378982544},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21824896335601807},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004892","descriptor_name":"Erythema Multiforme","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006561","descriptor_name":"Herpes Simplex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006680","descriptor_name":"HLA Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009660","descriptor_name":"Northern Ireland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015234","descriptor_name":"HLA-A Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015235","descriptor_name":"HLA-B Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1399-0039.1983.tb00169.x","doi":"https://doi.org/10.1111/j.1399-0039.1983.tb00169.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1399-0039.1983.tb00169.x","pdf_url":null,"source":{"id":"https://openalex.org/S141055564","display_name":"Tissue Antigens","issn_l":"0001-2815","issn":["0001-2815","1399-0039"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tissue Antigens","raw_type":"journal-article"},{"id":"pmid:6574617","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6574617","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tissue antigens","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1737967467","https://openalex.org/W1965909560","https://openalex.org/W2001284250","https://openalex.org/W2168767663","https://openalex.org/W2273266675","https://openalex.org/W2409153925"],"related_works":["https://openalex.org/W2168365146","https://openalex.org/W2080992748","https://openalex.org/W4230060560","https://openalex.org/W2063698297","https://openalex.org/W2387235617","https://openalex.org/W2033831968","https://openalex.org/W136906522","https://openalex.org/W2139616534","https://openalex.org/W2056768253","https://openalex.org/W2411357489"],"abstract_inverted_index":{"In":[0],"this":[1,88],"study":[2],"the":[3,63,74,79,96],"HLA":[4],"antigen":[5],"frequency":[6,37,46],"was":[7,49],"determined":[8],"in":[9,18,52,62],"a":[10,19,42],"group":[11,21,66],"of":[12,22,41,47,78,98],"patients":[13,23,82],"with":[14,24],"erythema":[15,64,80],"multiforme":[16,65,81],"and":[17,87],"separate":[20],"recurrent":[25],"herpes":[26,85],"simplex":[27,86],"to":[28,70,73],"establish":[29],"whether":[30],"either":[31],"disease":[32],"had":[33],"any":[34],"antigens":[35,99],"whose":[36],"deviated":[38],"from":[39],"that":[40,76],"normal":[43],"population.":[44],"The":[45,60],"HLA-B15":[48],"significantly":[50],"increased":[51],"both":[53],"patient":[54],"groups":[55],"(P":[56],"less":[57],"than":[58],"0.5).":[59],"increase":[61,89],"does":[67],"not":[68],"appear":[69],"be":[71],"due":[72],"fact":[75],"some":[77],"have":[83],"associated":[84],"remained":[90],"significant":[91],"after":[92],"further":[93],"correction":[94],"for":[95],"number":[97],"tested.":[100]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}